US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Jefast Borrower II AB (publ) announces that the condition for the early redemption of its bonds 2025/2027 with ISIN SE0025158504 has been fulfilled

Jefast Borrower II AB (publ) announces that the condition for the early redemption of its bonds 2025/2027 with ISIN SE0025158504 has been fulfilled Jefast Borrower II AB (publ) (“Jefast” and the “Company”) announced on 2 June 2026 that it will redeem in full all of its outstanding bonds 2025/2027 with ISIN SE0025158504 issued on 24 June 2025 (the “Bonds” and the “Early Redemption” respectively). The Early Redemption was conditional upon the successful closing of a financing transaction (the “Refinancing”) for the purpose of refinancing the Bonds. The Refinancing has been completed and

Jefast Borrower II AB (publ) gives notice of conditional early redemption of its bonds 2025/2027 with ISIN SE0025158504

Jefast Borrower II AB (publ) gives notice of conditional early redemption of its bonds 2025/2027 with ISIN SE0025158504 Jefast Borrower II AB (publ) (“Jefast” and the “Company”) has today instructed CSC (Sweden) AB, in its capacity as agent, to send a conditional notice of early redemption of all outstanding bonds 2025/2027 with ISIN SE0025158504 issued on 24 June 2025 and with a total outstanding nominal amount of SEK 350,000,000 (the “Bonds”), in accordance with the terms and conditions of the Bonds (the “Terms and Conditions”). The date for the early redemption is set to 15 July

Jefast Borrower II AB (publ) publishes its year-end report for the period January-March 2026

Please see a summary of the highlights from the quarterly report below as well as the full report attached to this pressrelease, which is also available on the website: www.jefast.sePeriod Jan-Mar 2026* Revenue amounted to 8.5 MSEK* Operating profit amounted to 2.5 MSEK* Net loan to value amounted to 63.13%for the Borrower II Group and 52.88% fortheJefast AB Group* Property value amounted to 540 MSEK forthe Borrower II Group and 2 266 MSEKfor the Jefast AB Group Events in the reporting period* No major events took place in thereporting period Events after the

Jefast Borrower II AB (publ) publishes its year-end report for the period January-December 2025

Please see a summary of the highlights from the quarterly report below as well as the full report attached to this pressrelease, which is also available on the website: www.jefast.sePeriod Oct- Dec 2025 * Revenue amounted to 8.7 MSEK * Operating profit amounted to 3.0 MSEK Period Jan-Sept 2025 * Revenue amounted to 33.4 MSEK * Operating profit amounted to 13.0 MSEK * Net loan to value amounted to 63.8% for the Borrower II Group and 52.9% for the Jefast AB Group * Property value amounted to 540 MSEK for the Borrower II Group and 2 266 MSEK for the Jefast AB Group

Jefast Borrower II AB (publ) publishes its interrim report for the period January-September 2025

Please see a summary of the highlights from the quarterly report below as well as the full report attached to this pressrelease, which is also available on the website: www.jefast.sePeriodJuly-Sept 2025* Revenueamountedto 8.3MSEK* Operating profitamountedto 3.3MSEK PeriodJan Sept2025* Revenueamountedto 24.7MSEK* Operating profitamountedto 10.0MSEK* Netloan tovalueamountedto 67.38%for theBorrowerII Groupand57.38%for theJefast ABGroup* Propertyvalueamountedto 505MSEK fortheBorrowerII Groupand 2 081

Jefast Borrower II AB (publ) publishes its interrim report for the period January-June 2025

Please see a summary of the highlights from the quarterly report below as well as the full report attached to this pressrelease, which is also available on the website: www.jefast.se   Period    April -June 2025* Revenue    amountedto 8.3MSEK* Operating  profitamountedto 3.7MSEK         Period Jan    - June2025* Revenue    amountedto 16.4MSEK* Operating  profitamountedto 6.7MSEK* Net loanto valueamountedto 67.61%for theBorrowerII Groupand 57.73%for theJefast AB

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe